Small Talk: Great Eastern Energy taps into India's growth

The Indian economy is growing fast. Last year's expansion is seen at about 8.4 per cent, and this year analysts are eying a similar performance of about 8.6 per cent. Goldman Sachs expects the country to notch up 8.7 per cent growth this year before cooling a little in 2012, when it sees 8.3 per cent growth in India's gross domestic product.

The strength calls for a variety of things – not least energy, which is needed to power the country's factories and offices. This is where Great Eastern Energy Corporation comes in.

The business, founded nearly two decades ago, was awarded its first concession to explore for coal bed methane, or CBM, in India's West Bengal state in 2001. Last year, it snapped up a second block in the southern Tamil Nadu state.

Simply put, CBM is natural gas trapped in coal seams. In West Bengal, Great Eastern extracts the gas, and, using its own infrastructure, pipes it out to customers in the industrial region close to the block. Customers range from small to large enterprises keen to have a reliable source of fuel, and Great Eastern, which is expected to post an interim management statement soon, also sells compressed natural gas at retail outlets in and around its licence area.

The market, as we mentioned earlier, is fertile. Back in 2009, imports met around 74 per cent of India's crude oil, some 13 per cent of its coal and nearly a quarter of its natural gas needs, according to the analysts at Religare. International Energy Agency figures suggest that primary energy demand will continue rising in coming years, with growth between 2006 and 2030 seen at about 3.5 per cent, against 1.6 per cent for the world as a whole.

Natural gas ranks number three in the country's energy basket, and though the Indian gas market is currently quite small compared with the UK and US, it has been growing. Analysts expect a continuation of this trend, boding well for the likes of Great Eastern.

Rockhopper set to scale new heights

Sticking with the oil and gas theme, take a look at Rockhopper Exploration, the oil prospector focused on the Falklands Islands, which enjoyed quite a run over the past 12 months. Despite some uninspiring news in October, when Rockhopper warned it lacked data for a planned technical report to support its initial resource estimate at its closely followed discovery at the Sea Lion well, the stock was up nearly 500 per cent over 2010.

Impressive as that is, Panmure Gordon reckons that Rockhopper could rally even higher this year. In a round-up of its top picks issued late last week, it reiterated its 530p target price, well above the current share price of 373p, and named the company as its top choice in the oil exploration and production sector. Panmure reckons there should be an additional upside at Sea Lion, pointing out that as the initial well threw up thicker sands than expected, "the company would want to see if this is repeated across the rest of the prospect, [thus] allowing an increase in volumes". The investment bank also highlights Rockhopper's potential to expand the discovery to the south, pointing out that it is fully funded and boasts some attractive exploration opportunities.

"Having proved that the play works with Sea Lion, the company could acquire additional three-dimensional data on its acreage. This should identify additional prospects that can be drilled in the current campaign, adding significant shareholder value," Panmure explained. "Should Sea Lion prove to be commercial, smaller discoveries could be inexpensively tied into any infrastructure that is put into place." Investors will no doubt have their fingers crossed for further gains.

Sinclair Pharma targets Asia Pacific

In December, investors in Sinclair Pharma saw a flurry of deals – four in less than 10 days, in fact. The month began with the company signing a licence agreement with Medpharm to develop a patented new spray for athlete's foot.

The speciality pharmaceuticals group followed that up with the acquisition of Cranage Healthcare, a distributor of wound care products, and with a partnership deal with Invida to market its dermatology and wound care products in the Asia-Pacific region, initially in the lucrative markets of Australia, China, Hong Kong, Indonesia and Singapore.

The Invida deal was particularly well received by the market, with analysts at Singer noting that "further out, launching the majority of Sinclair Pharma's portfolio in South east Asia with a such a major distributor ... could significantly influence [its] outlook and value".

The final development was news of a partnership deal with Sunstar, one of the leading oral care companies in the world, to launch Sinclair's mouthwash product, Decapinol, in the US.

All this has driven Sinclair's share price from about 31p at the beginning to December to 41p. The comeback must be a relief for investors who bought in around October 2009, when the stock was trading at 44p. The intervening period saw it slide to 25.5p, a level it was trading at as recently as last August. If the recent momentum is anything to go by, they may be in for a happy new year.

As a meter, the finance director Alan Olby recently signalled that Asia-Pacific may just mark the beginning of a full-fledged push into emerging markets, saying: "We are looking to roll out into the Middle East, Eastern Europe and South America, and India as well. We are in some discussions on deals in key territories."

Suggested Topics
Start your day with The Independent, sign up for daily news emails
election 2015The 10 best quotes of the campaign
A caravan being used as a polling station in Ford near Salisbury, during the 2010 election
election 2015The Independent's guide to get you through polling day
David Blunkett joins the Labour candidate for Redcar Anna Turley on a campaigning visit last month
voicesWhat I learnt from my years in government, by the former Home Secretary David Blunkett
ebooksA celebration of British elections
  • Get to the point
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Ashdown Group: Editor-in-chief - Financial Services - City, London

£60000 - £70000 per annum + benefits : Ashdown Group: A highly successful, glo...

Ashdown Group: Junior Application Support Analyst - Fluent German Speaker

£25000 - £30000 per annum + benefits: Ashdown Group: A global leader operating...

Guru Careers: Management Accountant

£27 - 35k + Bonus + Benefits: Guru Careers: A Management Accountant is needed ...

Guru Careers: Project Manager / Business Analyst

£40-50k + Benefits.: Guru Careers: A Project Manager / Business Analyst is nee...

Day In a Page

General Election 2015: ‘We will not sit down with Nicola Sturgeon’, says Ed Balls

'We will not sit down with Nicola Sturgeon'

In an exclusive interview, Ed Balls says he won't negotiate his first Budget with SNP MPs - even if Labour need their votes to secure its passage
VE Day 70th anniversary: How ordinary Britons celebrated the end of war in Europe

How ordinary Britons celebrated VE Day

Our perception of VE Day usually involves crowds of giddy Britons casting off the shackles of war with gay abandon. The truth was more nuanced
They came in with William Caxton's printing press, but typefaces still matter in the digital age

Typefaces still matter in the digital age

A new typeface once took years to create, now thousands are available at the click of a drop-down menu. So why do most of us still rely on the old classics, asks Meg Carter?
Discovery of 'missing link' between the two main life-forms on Earth could explain evolution of animals, say scientists

'Missing link' between Earth's two life-forms found

New microbial species tells us something about our dark past, say scientists
The Pan Am Experience is a 'flight' back to the 1970s that never takes off - at least, not literally

Pan Am Experience: A 'flight' back to the 70s

Tim Walker checks in and checks out a four-hour journey with a difference
Humans aren't alone in indulging in politics - it's everywhere in the animal world

Humans aren't alone in indulging in politics

Voting, mutual back-scratching, coups and charismatic leaders - it's everywhere in the animal world
Crisp sales are in decline - but this tasty trivia might tempt back the turncoats

Crisp sales are in decline

As a nation we're filling up on popcorn and pitta chips and forsaking their potato-based predecessors
Ronald McDonald the muse? Why Banksy, Ron English and Keith Coventry are lovin' Maccy D's

Ronald McDonald the muse

A new wave of artists is taking inspiration from the fast food chain
13 best picnic blankets

13 best picnic blankets

Dine al fresco without the grass stains and damp bottoms with something from our pick of picnic rugs
Barcelona 3 Bayern Munich 0 player ratings: Lionel Messi scores twice - but does he score highest in our ratings?

Barcelona vs Bayern Munich player ratings

Lionel Messi scores twice - but does he score highest in our ratings?
Martin Guptill: Explosive New Zealand batsman who sets the range for Kiwis' big guns

Explosive batsman who sets the range for Kiwis' big guns

Martin Guptill has smashed early runs for Derbyshire and tells Richard Edwards to expect more from the 'freakish' Brendon McCullum and his buoyant team during their tour of England
General Election 2015: Ed Miliband's unlikely journey from hapless geek to heart-throb

Miliband's unlikely journey from hapless geek to heart-throb

He was meant to be Labour's biggest handicap - but has become almost an asset
General Election 2015: A guide to the smaller parties, from the the National Health Action Party to the Church of the Militant Elvis Party

On the margins

From Militant Elvis to Women's Equality: a guide to the underdogs standing in the election
Amr Darrag: Ex-Muslim Brotherhood minister in exile still believes Egypt's military regime can be replaced with 'moderate' Islamic rule

'This is the battle of young Egypt for the future of our country'

Ex-Muslim Brotherhood minister Amr Darrag still believes the opposition can rid Egypt of its military regime and replace it with 'moderate' Islamic rule, he tells Robert Fisk
Why patients must rely less on doctors: Improving our own health is the 'blockbuster drug of the century'

Why patients must rely less on doctors

Improving our own health is the 'blockbuster drug of the century'